Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Postoperative Delirium in Elderly Orthopedic Surgery Patients
NCT05514405Recruiting
- Sponsor
- Inje University
- Start
- Aug 2022
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in postoperative delirium (POD) (2 arms), sponsored by Inje University. Primary endpoint: Incidence of postoperative delirium at 3 days. Started Aug 2022; status: recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT05514405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05514405.